CT Scanner Market to Reach USD 11.41 Billion by 2032 at 5.8% CAGR

Key Highlights

• The CT Scanner Market was valued at USD 7.69 billion in 2025 and is expected to reach USD 11.41 billion by 2032, expanding at a 5.8% CAGR from 2026 to 2032. For hospitals and imaging providers, that growth points to continued capital spending on systems that combine faster acquisition, better resolution and lower radiation exposure.
• Oncology is expected to dominate applications during the forecast period because CT supports cancer diagnosis, metastatic disease detection, radiation planning, surgical planning and treatment-response monitoring.
• North America dominated in 2025 and is expected to retain leadership, supported by advanced healthcare infrastructure, chronic disease burden, aging populations, R&D activity and favourable reimbursement conditions.
• Canon Medical Systems is integrating AI into CT workflows, image reconstruction and automated positioning, signalling a transition from hardware competition toward software-enabled clinical productivity.
• Fujifilm's FCT iStream uses iterative reconstruction designed to reduce radiation dose by as much as 83% compared with earlier systems cited by the report. That strengthens the commercial case for scanners that improve safety without sacrificing diagnostic utility.

Why This Matters Now

Diagnostic imaging departments face a difficult combination: higher patient demand, pressure to shorten examination times and greater scrutiny of radiation exposure. CT technology is responding with faster scanning, higher slice counts, automated workflows and AI-assisted reconstruction.

For the CT Scanner Market, the strategic shift is clear. Hospitals are no longer buying imaging hardware solely on image quality; workflow automation, radiation management, throughput and clinical versatility increasingly influence equipment decisions. Canon's latest systems illustrate that change by combining higher-resolution scanning with extensive AI support.

Market Overview

Computed tomography uses narrow X-ray beams moving around the body to produce detailed cross-sectional images. Detectors capture numerous density levels and send them to computers that construct three-dimensional images, allowing physicians to inspect tissues, organs and blood vessels with greater detail than conventional single-beam X-ray imaging.

Download PDF Brochure: https://www.maximizemarketresearch.com/request-sample/9329/

The CT Scanner Market is projected to expand from USD 7.69 billion in 2025 to USD 11.41 billion in 2032 at a 5.8% CAGR. The business implication extends beyond scanner sales: growing adoption increases demand for imaging infrastructure, workflow software, maintenance capabilities and specialised radiology expertise.

Spiral CT technology further improves speed and accuracy by collecting continuous information without image gaps. Yet ionising radiation remains a clinical consideration, making dose reduction one of the clearest areas where manufacturers can differentiate new systems.

Key Trends Driving Growth

AI integration is changing the economics of medical imaging. Canon's Aquilion ONE / INSIGHT Edition and Aquilion Serve SP use AI technologies for workflow support, image quality improvements and automated processes, including automated iso-centering. These capabilities can reduce repetitive tasks while allowing clinicians to spend more time on patient-facing work.

The CT Scanner Market is also moving toward higher-resolution and higher-throughput systems. Canon's Aquilion ONE / INSIGHT Edition offers 640 slices and can scan the heart or brain in one rotation, while the Aquilion Serve SP uses a 160-slice configuration designed around throughput. The commercial direction is toward systems that process complex cases faster without weakening image quality.

Dose management remains equally important. Fujifilm introduced the compact 128-slice FCT iStream using iterative reconstruction, with the report citing up to an 83% radiation-dose reduction compared with earlier systems. Lower radiation requirements strengthen the clinical case for scanner replacement and technology upgrades.

Competitive pressure is also becoming more global. China-based United Imaging showcased multiple CT systems with integrated AI and competitive pricing as it targeted greater US penetration. That strategy suggests established manufacturers will face growing pressure to justify premium pricing through software, workflow automation and clinical differentiation.

Segment Insights

• Dominant Segment  Oncology: Oncology is expected to dominate applications. CT imaging detects metastases, defines tumour boundaries, supports radiation planning, guides surgical approaches and tracks treatment response. That makes scanners part of the full cancer-care pathway rather than a single diagnostic event.
• Type Low Slice: The CT Scanner Market segments technology into low-slice, medium-slice and high-slice systems. Low-slice systems remain part of the product structure, serving imaging environments where clinical requirements do not necessarily demand the highest acquisition capability. The report does not provide a separate share figure.
• Type  Medium Slice: Medium-slice systems form the middle tier of the technology segmentation. They offer a position between entry-level imaging and advanced high-slice platforms, although the source does not provide a market share or growth rate for this category.
• Type  High Slice: High-slice systems address more advanced imaging requirements where speed, anatomical coverage and image detail matter. Product development such as 640-slice and 160-slice systems shows manufacturers concentrating innovation at the higher-performance end of the portfolio.
• End Users: Hospitals, diagnostic centres and other facilities make up the end-user segmentation. This structure places equipment purchasing decisions across major hospital networks and specialised imaging providers rather than a single care setting.
• Fastest-Growing Segment: The supplied MMR source does not identify a fastest-growing type, application or end-user segment. No unsupported ranking is assigned.

Regional Growth Story

North America dominated the CT Scanner Market in 2025 and is expected to retain its position. Advanced healthcare infrastructure, strong adoption of medical technologies, chronic disease prevalence, an aging population and continued R&D spending support equipment demand. Favourable reimbursement policies and an established regulatory environment also encourage healthcare facilities to expand imaging capabilities.

The United States benefits from a dense ecosystem of scanner manufacturers, healthcare providers, research institutions and technology developers. Collaboration among these groups supports adoption across oncology, cardiology and neurology, strengthening the commercial case for increasingly specialised systems.

Europe includes the UK and Germany within the report's regional assessment, while Asia Pacific covers China, Japan, India and South Korea. The source does not publish country-level revenue or growth figures for these markets, so numerical comparisons would be unsupported.

Asia Pacific nevertheless has a significant competitive manufacturing presence. Canon Medical Systems and Fujifilm are headquartered in Japan, while Neusoft is based in China; the report also identifies Omron, Toshiba IT & Control Systems and Shimadzu among regional participants.

Competitive Landscape

The CT Scanner Market includes General Electric, Siemens Medical Solutions USA, Canon Medical Systems, Fujifilm, NeuroLogica, Neusoft, Shimadzu, Omron and other equipment suppliers. Competition increasingly spans image quality, workflow automation, dose reduction, regulatory clearance and acquisition speed rather than basic scanner availability.

Canon's product strategy signals the industry's direction. AI integration across image reconstruction, positioning and workflow can raise scanner utilisation while helping radiology departments handle greater examination volumes. Regulatory clearance therefore becomes more than a compliance milestone: it determines how quickly advanced features can move into clinical practice.

United Imaging's push toward the US with competitively priced, AI-integrated scanners introduces another pressure point. If price competition intensifies, incumbents will need stronger clinical evidence and productivity advantages to defend premium systems.

Download PDF Brochure: https://www.maximizemarketresearch.com/request-sample/9329/

Recent Developments

• On March 13, 2025, Canon Medical Systems announced regulatory clearances for its Aquilion ONE / INSIGHT Edition with PIQE 1024 matrix and SilverBeam technologies. The development broadens AI-supported ultra-high-resolution and low-dose imaging workflows.
• On July 3, 2025, Siemens Healthineers obtained a US regulatory clearance cited by MMR. Regulatory progress strengthens the route for new CT technology adoption in the world's leading regional market.
• Canon introduced the Aquilion ONE / INSIGHT Edition and Aquilion Serve SP with extensive AI integration, targeting faster workflows, better image quality and automation.
• Fujifilm launched the compact 128-slice FCT iStream using iterative reconstruction to reduce radiation exposure. The source states the system had not yet received FDA clearance at the time discussed.
• United Imaging showcased AI-integrated systems as part of its effort to enter the US with competitively priced CT equipment, signalling greater price and technology competition.

Strategic Implications

For hospital executives, the CT Scanner Market increasingly requires a total-workflow investment decision. Procurement teams must assess image quality alongside scan speed, radiation exposure, automation capabilities and utilisation potential.

For manufacturers, AI is becoming an embedded product capability rather than an optional software layer. Vendors that combine regulatory clearance with meaningful improvements in workflow and image reconstruction can strengthen both clinical adoption and long-term customer relationships.

Radiation reduction is another strategic differentiator. Systems that produce diagnostically useful images while lowering dose can support patient safety and create a stronger replacement case for aging scanner fleets.

Future Outlook

The CT Scanner Market will increasingly be shaped by the convergence of high-resolution hardware, AI-assisted reconstruction, automated workflow and lower-dose imaging. Oncology will remain a critical use case because CT supports diagnosis, staging, treatment planning and response monitoring across the cancer pathway.

The next competitive threshold will not be defined by slice count alone. Healthcare organisations that combine advanced scanners with faster clinical workflows and safer imaging protocols will gain capacity and diagnostic efficiency; those that treat CT modernisation as a hardware replacement exercise will fall behind.

Browse More Trending Reports

Global Peptic Ulcer Market 

Global Coagulation Testing

Analyst Perspective

“CT technology is moving rapidly from image acquisition toward intelligent diagnostic workflow. AI integration, faster scanning and radiation-dose reduction are creating a stronger value case for hospitals because the benefits extend from image quality to patient throughput and clinical efficiency,” said Komal Patil, Analyst at Maximize Market Research.

About Maximize Market Research

Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting company that provides reliable, data-focused, and practical business insights. The firm serves a wide range of industries, including healthcare, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. Through market forecasts, competitive analysis, strategic consulting, and industry impact assessments, MMR helps organizations understand changing market conditions, identify growth opportunities, and make informed business decisions for long-term success.

Contact Us

2nd Floor, Navale IT Park Phase 3

Pune Banglore Highway, Narhe

Pune, Maharashtra 411041, India

+91 9607365656

sales@maximizemarketresearch.com 

https://www.maximizemarketresearch.com